| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121366 | Journal of Clinical Virology | 2013 | 4 Pages |
Abstract
Most CMV-seropositive liver recipients did not develop CMV reactivation, and if reactivations occurred, most were temporal, low-level DNAaemias. Significant CMV infections were successfully treated and recurrences were rare.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo, Krister Höckerstedt,